Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;

NCT04738188 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

226

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: DEB-TACE
PROCEDURE: cTACE
DEVICE: Drug-eluting Beads
DRUG: Epirubicin

Sponsor

Beijing Tsinghua Chang Gung Hospital